Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6759168rdf:typepubmed:Citationlld:pubmed
pubmed-article:6759168lifeskim:mentionsumls-concept:C0030933lld:lifeskim
pubmed-article:6759168lifeskim:mentionsumls-concept:C0072603lld:lifeskim
pubmed-article:6759168lifeskim:mentionsumls-concept:C0066672lld:lifeskim
pubmed-article:6759168pubmed:issue2lld:pubmed
pubmed-article:6759168pubmed:dateCreated1983-3-11lld:pubmed
pubmed-article:6759168pubmed:abstractTextA spermine-dependent, polyphenylalanine-synthesizing cell-free system having an optimum activity at 75-85 degrees C, has been developed from the extremely thermoacidophilic archaebacterium Caldariella acidophila. The C. acidophila system is totally insensitive to the EF-Tu targeted antibiotics pulvomycin (at 40 degrees C) and kirromycin (at 47-72 degrees C) contrary to control systems derived from both mesophilic (Escherichia coli) and thermoacidophilic (Bacillus acidocaldarius) eubacteria. The archaebacterial EF-Tu-equivalent factor is also immunologically unrelated to eubacterial EF-Tu and does not cross react with antibodies against Escherichia coli EF-Tu. The pulvomycin and kirromycin reactions thus provide new phyletic markers for archaebacterial ancestry.lld:pubmed
pubmed-article:6759168pubmed:languageenglld:pubmed
pubmed-article:6759168pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6759168pubmed:citationSubsetIMlld:pubmed
pubmed-article:6759168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6759168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6759168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6759168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6759168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6759168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6759168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6759168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6759168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6759168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6759168pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6759168pubmed:statusMEDLINElld:pubmed
pubmed-article:6759168pubmed:monthNovlld:pubmed
pubmed-article:6759168pubmed:issn0014-5793lld:pubmed
pubmed-article:6759168pubmed:authorpubmed-author:GambacortaAAlld:pubmed
pubmed-article:6759168pubmed:authorpubmed-author:de RosaMMlld:pubmed
pubmed-article:6759168pubmed:authorpubmed-author:ChinaliGGlld:pubmed
pubmed-article:6759168pubmed:authorpubmed-author:NicolauxGGlld:pubmed
pubmed-article:6759168pubmed:authorpubmed-author:CammaranoPPlld:pubmed
pubmed-article:6759168pubmed:authorpubmed-author:LondeiPPlld:pubmed
pubmed-article:6759168pubmed:authorpubmed-author:TeichnerAAlld:pubmed
pubmed-article:6759168pubmed:issnTypePrintlld:pubmed
pubmed-article:6759168pubmed:day8lld:pubmed
pubmed-article:6759168pubmed:volume148lld:pubmed
pubmed-article:6759168pubmed:ownerNLMlld:pubmed
pubmed-article:6759168pubmed:authorsCompleteYlld:pubmed
pubmed-article:6759168pubmed:pagination255-9lld:pubmed
pubmed-article:6759168pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6759168pubmed:meshHeadingpubmed-meshheading:6759168-...lld:pubmed
pubmed-article:6759168pubmed:meshHeadingpubmed-meshheading:6759168-...lld:pubmed
pubmed-article:6759168pubmed:meshHeadingpubmed-meshheading:6759168-...lld:pubmed
pubmed-article:6759168pubmed:meshHeadingpubmed-meshheading:6759168-...lld:pubmed
pubmed-article:6759168pubmed:meshHeadingpubmed-meshheading:6759168-...lld:pubmed
pubmed-article:6759168pubmed:meshHeadingpubmed-meshheading:6759168-...lld:pubmed
pubmed-article:6759168pubmed:meshHeadingpubmed-meshheading:6759168-...lld:pubmed
pubmed-article:6759168pubmed:meshHeadingpubmed-meshheading:6759168-...lld:pubmed
pubmed-article:6759168pubmed:meshHeadingpubmed-meshheading:6759168-...lld:pubmed
pubmed-article:6759168pubmed:meshHeadingpubmed-meshheading:6759168-...lld:pubmed
pubmed-article:6759168pubmed:meshHeadingpubmed-meshheading:6759168-...lld:pubmed
pubmed-article:6759168pubmed:meshHeadingpubmed-meshheading:6759168-...lld:pubmed
pubmed-article:6759168pubmed:meshHeadingpubmed-meshheading:6759168-...lld:pubmed
pubmed-article:6759168pubmed:meshHeadingpubmed-meshheading:6759168-...lld:pubmed
pubmed-article:6759168pubmed:meshHeadingpubmed-meshheading:6759168-...lld:pubmed
pubmed-article:6759168pubmed:year1982lld:pubmed
pubmed-article:6759168pubmed:articleTitleArchaebacterial elongation factor Tu insensitive to pulvomycin and kirromycin.lld:pubmed
pubmed-article:6759168pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6759168pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6759168lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6759168lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6759168lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6759168lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6759168lld:pubmed